How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

358 results for

bell's palsy guideline

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Pandemic influenza vaccine H5N1 MedImmune

, colour, opalescence and appearance, sterility, and thermal stability. The analytical methods have been adequately described and (non-compendial methods) appropriately validated in accordance with ICH guidelines. Potency is determined with the fluorescent focus assay (see under active substance). The potential impurities in the P/LAIV finished product are endotoxin, ovalbumin and other egg-derived proteins, and residual process and excipient components (Gentamicin Sulfate), which are also present

2016 European Medicines Agency - EPARs

122. Diagnosis and Management of Prosthetic Joint Infection

Diagnosis and Management of Prosthetic Joint Infection We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa | Clinical Infectious Diseases | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close (...) search filter search input Article Navigation Close mobile search navigation Article navigation 1 January 2013 Article Contents Article Navigation Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America Douglas R. Osmon 1Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota Correspondence: Douglas R. Osmon, Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic College

Full Text available with Trip Pro

2013 Infectious Diseases Society of America

123. An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare professionals from the American Heart Association/American Stroke Association

and contrasting studies in which different definitions are used for inclusion of cases or ascertainment of outcomes is difficult. The advent of thrombolysis and other hyperacute treatments has added to the need to redefine stroke and TIA, because many current guidelines differentiate treatment strategies for these 2 entities. Treatment of patients with CNS ischemia should be directed to the cause and not governed only by whether infarction has developed. However, the location and extent of infarction is one

Full Text available with Trip Pro

2013 Congress of Neurological Surgeons

124. An updated definition of stroke for the 21st century

is difficult. The advent of thrombolysis and other hyperacute treatments has added to the need to redefine stroke and TIA, because many current guidelines differentiate treatment strategies for these 2 entities. Treatment of patients with CNS ischemia should be directed to the cause and not governed only by whether infarction has developed. However, the location and extent of infarction is one variable to consider when choosing treatment. Time and Imaging Early definitions of stroke and TIA focused

Full Text available with Trip Pro

2013 American Academy of Neurology

125. Occipital Condyle Fractures

should be considered for bilateral OCF. Halo vest immobilization or occipitocervical stabilization and fusion are recommended for injuries with associated atlanto occipital ligamentous injury or evidence of instability. RATIONALE Acute traumatic OCF was first described by Bell in 1817. More frequent observations of this injury have been reported during the past 2 decades. Improvements in CT imaging technology and the use of CT imaging of head-injury patients that includes visualization (...) treatment strategies for OCF including no treatment, traction, external immobilization, and surgical decompression with internal fixation and fusion. The guidelines author group of the Section on Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) produced a medical evidence-based guideline on this topic in 2002. The purpose of the current review is to update the medical evidence on the diagnosis

Full Text available with Trip Pro

2013 Congress of Neurological Surgeons

126. Post-Operative Management of Legg-Calve-Perthes Disease In children aged 3 to 12 years

Post-Operative Management of Legg-Calve-Perthes Disease In children aged 3 to 12 years Evidence-Based Care Guideline for Management of Legg-Calve-Perthes Disease Stages 1 to 4 Status-post Surgical Intervention in Children aged 3 to 12 years Guideline 41 Copyright © 2013 Cincinnati Children's Hospital Medical Center; all rights reserved. Page 1 James M. Anderson Center for Health Systems Excellence Evidence-Based Care Guideline Post-Operative Management of Legg-Calve-Perthes Disease In children (...) : Children with the following: o Conservative management of LCP o Other diagnosis of avascular necrosis in hip o Femoral head injury or fracture o Slipped capital femoral epiphysis o Femur fracture o Acetabular or pelvis fracture o LCP present with other hip condition o Acetabular labral tear o Cancer or bone tumor in femur o Arthritis in hip o Hip dysplasia o Cerebral palsy a Please cite as: Lee J, Allen M, Hugentobler K, Kovacs C, Monfreda J, Nolte B, Woeste E; Cincinnati Children's Hospital Medical

2013 Cincinnati Children's Hospital Medical Center

127. Treatment of Osteoarthritis of the Knee

Treatment of Osteoarthritis of the Knee TREATMENT OF OSTEOARTHRITIS OF THE KNEE EVIDENCE-BASED GUIDELINE 2 ND EDITION Adopted by the American Academy of Orthopaedic Surgeons Board of Directors May 18, 2013 i Disclaimer This clinical practice guideline was developed by an AAOS work group comprised of volunteer physicians and interdisciplinary clinicians as well as staff researchers with expertise in systematic reviews and statistical methods used to evaluate empirical evidence (...) . It is an educational tool that integrates the current scientific literature and the proficiency and sound judgment that physicians typically acquire in clinical practice. The recommendations that make up this guideline are not intended to be absolute as patients vary in how they experience symptoms and respond to treatment interventions. There may be variability between patients in practice and those who participate in clinical trials. Medical care should always be based on a physician’s expertise

2013 American Academy of Orthopaedic Surgeons

128. Management of Thyroid Cancer

Management of Thyroid Cancer CLINICAL ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF THE SOCIETY FOR ENDOCRINOLOGY AND THE ENDOCRINE SOCIETY OF AUSTRALIA British Thyroid Association Guidelines for the Management of Thyroid CancerGuidelines for the management of thyroid cancer Third edition British Thyroid Association July 2014 Perros P, Colley S, Boelaert K, Evans C, Evans RM, Gerrard GE, Gilbert JA, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V , Newbold KL (...) , Taylor J, Thakker RV , Watkinson J, Williams GR cen_frontmatter.indd i cen_frontmatter.indd i 6/27/2014 3:52:19 PM 6/27/2014 3:52:19 PMii Acknowledgements Grateful thanks are expressed to the many reviewers of these guidelines. These included leading international experts in thyroid cancer, hospital specialists, and general practitioners. They devoted much time and care to considering the document and their recommendations and suggestions for improvements were most valuable. Special thanks to Dr

2014 British Association of Endocrine and Thyroid Surgeons

129. Eye movement assessment protocol

, allowing for their detailed 144 analysis. 145 The aim of this recommended procedure is to clarify the methodology and 146 interpretation of findings. This should allow a standardised method to be used in 147 most cases. Alternative methodologies may be required in certain cases, but 148 there must be robust evidence to justify doing so. 149 3.3. Scope 150 This protocol provides guidelines for testing using ENG or VNG with 151 commercially available systems. The test battery is used for the assessment (...) with eyes closed 215 Although not recommended, some tests can be carried out with eyes closed (e.g. 216 search for spontaneous or gaze-evoked nystagmus without visual fixation, 217 rotational and caloric tests) but one should be aware of artefacts, such as non- 218 pathological up-beating spontaneous nystagmus (SN) and Bell’s phenomenon. 219 4.4. Visual impairments and ophthalmic disorders 220 Blindness or severe visual impairment may affect the results. If a patient with 221 significant refractive

2014 British Society of Audiology

130. Management of suspected viral encephalitis in children

Management of suspected viral encephalitis in children Management of suspected viral encephalitis in children – Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group National Guidelines - Journal of Infection Email/Username: Password: Remember me Search Terms Search within Search Access provided by Volume 64, Issue 5, Pages 449–477 Management of suspected viral encephalitis in children – Association of British Neurologists and British Paediatric (...) Allergy, Immunology and Infection Group National Guidelines x R. Kneen Affiliations Alder Hey Children's NHS Foundation Trust, Eaton Road, West Derby, Liverpool L12 2AP, UK Institute of Infection and Global Health, University of Liverpool, 8th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK Correspondence Corresponding author. Tel.: +44 151 228 4811; fax: +44 151 228 032. a , b , r , ∗ , x R. Kneen Affiliations Alder Hey Children's NHS Foundation Trust, Eaton Road, West Derby, Liverpool

Full Text available with Trip Pro

2012 British Infection Association

131. Treatment of Pediatric Supracondylar Humerus Fractures

Treatment of Pediatric Supracondylar Humerus Fractures THE TREATMENT OF PEDIATRIC SUPRACONDYLAR HUMERUS FRACTURES EVIDENCE- BASED GUIDELINE AND EVIDENCE REPORT Adopted by the American Academy of Orthopaedic Surgeons Board of Directors September 24, 2011 AAOS Clinical Practice Guidelines Unit v1.0_092311 ii Disclaimer This Clinical Practice Guideline was developed by an AAOS physician volunteer Work Group based on a systematic review of the current scientific and clinical information (...) and accepted approaches to treatment and/or diagnosis. This Clinical Practice Guideline is not intended to be a fixed protocol, as some patients may require more or less treatment or different means of diagnosis. Clinical patients may not necessarily be the same as those found in a clinical trial. Patient care and treatment should always be based on a clinician’s independent medical judgment, given the individual patient’s clinical circumstances. Disclosure Requirement In accordance with AAOS policy, all

2011 American Academy of Orthopaedic Surgeons

132. CPG on sleep disorders in childhood and adolescence in primary care

CPG on sleep disorders in childhood and adolescence in primary care Clinical Practice Guideline on Sleep Disorders in Childhood and Adolescence in Primary Care CLINICAL PRACTICE GUIDELINTES IN THE NHS MINISTRY OF HEALTH, SOCIAL SERVICES AND EQUALITY MINISTERIO DE CIENCIA E INNOVACIÓN MINISTERIO DE SANIDAD, POLÍTICA SOCIAL E IGUALDADIt has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. MINISTERIO E INNOVACIÓN DE CIENCIA MINISTERIO DE SANIDAD (...) , POLÍTICA SOCIAL E IGUALDAD Clinical Practice Guideline on Sleep Disorders in Childhood and Adolescence in Primary Care CLINICAL PRACTICE GUIDELINTES IN THE NHS MINISTRY OF HEALTH, SOCIAL SERVICES AND EQUALITY It has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. This CPG is an aid for decision-making in healthcare. It is not mandatory, and it is not a substitute for the clinical judgement of healthcare personnel. Edition: 2011 Published

2011 GuiaSalud

133. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis Patients must not have undergone prior allogeneic bone marrow transplantation or prior solid organ transplantation Patient must not have active tuberculosis Patients must not have active hepatitis B (chronic or acute) or active hepatitis C infection Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B surface antigen [HBsAg (...) studies Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines As a part of the oncology patient enrollment network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system Contacts and Locations Go to Information from

2016 Clinical Trials

134. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

colitis, or other symptomatic lower GI conditions that might predispose to perforations History of autoimmune disease including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener?s granulomatosis, Sjogren?s syndrome, Bell?s palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis; Note: patients with a history of autoimmune (...) to randomization; hemoglobin must be stable >= 9 g/dL >= 14 days without blood transfusion to maintain hemoglobin level Calculated creatinine clearance must be >= 50 ml/min using the Cockcroft-Gault formula or a 24 hour urine obtained =< 7 days prior to randomization The following laboratory values obtained =< 14 days prior to randomization Prothrombin time (PT)/partial thromboplastin time (PTT)/international normalized ratio (INR) =< 1.5 X ULN if not anticoagulated; within local institutional guidelines per

2016 Clinical Trials

135. Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer

lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis; however, Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone may be eligible Patients with controlled type 1 diabetes mellitus on a stable insulin (...) : All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 Diagnosis of metastatic adenocarcinoma of colon or rectum without previous chemotherapy or any other systemic therapy for metastatic colorectal cancer Tumor determined to be mismatch-repair deficient (dMMR

2016 Clinical Trials

136. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

) is negative for HCV ribonucleic acid (RNA) History or risk of autoimmune disease, including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid (...) in the invasive component of the tumor (provided the patient is being treated as triple negative breast cancer) Human epidermal growth factor receptor 2 (HER2) negative by fluorescence in situ hybridization (FISH) or immunohistochemistry (IHC) staining 0 or 1+ according to National Comprehensive Cancer Network (NCCN) guidelines Clinical stage T2-T4c, any N, M0 primary tumor by American Joint Committee on Cancer (AJCC) 7th edition clinical staging Eligible for neoadjuvant chemotherapy No prior therapy

2016 Clinical Trials

137. Oral corticosteroid prescribing habits of Canadian Otolaryngologist-Head and Neck Surgeons (PubMed)

and tapering of OCSs were assessed in acute rhino-sinusitis (ARS), chronic rhino-sinusitis with (CRSwP) and without polyps (CRSsP), sudden sensori-neural hearing loss (SSNHL), and idiopathic facial nerve/Bell's palsy (IFN). Participants were asked to complete for conditions treated and results were compared with current guidelines. Development of prescribing habits and observed complications were also explored.124 surveys (18%) were completed. In CRSwP (N = 98), the median dose was 50 mg (Range: 10-100 mg

Full Text available with Trip Pro

2016 Journal of Otolaryngology - Head & Neck Surgery

138. Family Practice Notebook Updates 2016

Do not treat with a single drug regimen until is excluded by history, In suspected , mask patient in negative ariflow room and induce for AFB x3 samples has not changed substantially in 10 years, but multi-drug resistance guidelines are lacking (er, procedure, fen) Quick central access without Seldinger technique (id, std) Syphilis has increased 3-4 fold in the U.S. since 2000 (now at 20,000 cases per year) is typically treated with G (or , ) for primary and secondry Avoid in due to resistance (...) Gradually developed wbc to 3.5k, hgb from 13 to 12 to 11 over 1 week of serial visits for s demonstrated RBC inclusion bodies consistent with Updated to include In failed airway, may temporize in infants and young children for 20-25 min Covers reversal of specific s (e.g. DIC, TTP, disease, renal disease, s) or (id, immunize, ) Very low efficacy in U.S. as of 2016 (as low as 3%) and will not be used in U.S. per ACIP guidelines (endo, pharm, dm) For all its mediocre activity on lowering and adverse

2018 FP Notebook

139. Articles of the month (July 2016)

and art, but the very hopes and fears which make us men. In seeking out the absolute truth we aim for the unattainable, and must be content with finding broken portions.’’ Bottom line: Every doctor must be comfortable and quick to admit “I don’t know” Enough flip-flopping to make you think Cochrane is running for office Gagyor I, Madhok VB, Daly F. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). The Cochrane database of systematic reviews. 2015. PMID: This whole topic is a mess (...) and I don’t think I can sort it out for you. . This updated review adds 3 new trials and a total of 300 patients and they came to a different conclusion. However, this is a revised version of the review. The same author group published the same review earlier in 2015. At that point it included 1 more trial (of 500 patients) and their conclusions were that there was no significant benefit to adding antivirals to corticosteroids for the treatment of Bell’s palsy. That trial ( ) has been removed

2016 First10EM

140. Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning

Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning Management of patients with stroke: Rehabilitation, prevention and management of complications, and discharge planning A national clinical guideline June 2010 118 Scottish Intercollegiate Guidelines Network Part of NHS Quality Improvement Scotland SIGN Help us to improve SIGN guidelines - click here to complete our survey KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS (...) from studies rated as 1 ++ or 1 + C A body of evidence including studies rated as 2 + , directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2 ++ D Evidence level 3 or 4; or Extrapolated evidence from studies rated as 2 + GOOD PRACTICE POINTS ? Recommended best practice based on the clinical experience of the guideline development group NHS Evidence has accredited the process used by Scottish Intercollegiate

2010 SIGN

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>